Photo: ANDINA/Ministry of Health of Peru
02:10 | Lima, May. 13. The second wave of the COVID-19 pandemic in Peru shows a downward trend in important indicators, such as the percentage of new infections per week, the number of positive cases recorded per day, and the daily death toll, Health Minister Oscar Ugarte has reported. There is a trend towards a decline in three indicators: the percentage of infections and this is confirmed by the tests conducted on a daily basis, which are assessed week after week the daily cases, and the decline in the daily death toll, Ugarte explained.
According to the health sector s head, all we can do is wait until this favorable trend results in a significant reduction in the occupancy of hospital beds and, particularly, in the occupancy of ICU beds.
Chinese doses help close global vaccine disparity By ANGUS MCNEICE in London | China Daily | Updated: 2021-05-14 07:54 Share CLOSE People wait to be inoculated with COVID-19 vaccines developed by China s Sinopharm company at a vaccination center in Colombo, Sri Lanka, on Tuesday. ERANGA JAYAWARDENA/AP
Health experts say that an increased global reliance on Chinese COVID-19 vaccines cannot come soon enough, as other vaccines contend with delays in development and exportation.
Vaccines from Chinese pharmaceutical companies Sinopharm and Sinovac are about to play an increasingly vital role in the developing world, now that Astra-Zeneca exports from India have halted and United States biotechnology company Novavax has indicated that it is once again delaying regulatory submissions for approval of its vaccine.
Source：
2021-05-14 17:00
Health experts say that an increased global reliance on Chinese COVID-19 vaccines cannot come soon enough, as other vaccines contend with delays in development and exportation.
Vaccines from Chinese pharmaceutical companies Sinopharm and Sinovac are about to play an increasingly vital role in the developing world, now that Astra-Zeneca exports from India have halted and United States biotechnology company Novavax has indicated that it is once again delaying regulatory submissions for approval of its vaccine.
The World Health Organization recently listed the Sinopharm vaccine for emergency use, giving it the green light to be rolled out globally under the COVAX program, which distributes vaccines to developing nations.
Health experts say that an increased global reliance on Chinese COVID-19 vaccines cannot come soon enough, as other vaccines contend with delays in development and exportation.
Vaccines from Chinese pharmaceutical companies Sinopharm and Sinovac are about to play an increasingly vital role in the developing world, now that Astra-Zeneca exports from India have halted and United States biotechnology company Novavax has indicated that it is once again delaying regulatory submissions for approval of its vaccine.
The World Health Organization recently listed the Sinopharm vaccine for emergency use, giving it the green light to be rolled out globally under the COVAX program, which distributes vaccines to developing nations.
President Joe Biden’s administration took its biggest step yet towards declaring victory over the coronavirus pandemic – announcing that fully vaccinated Americans can ditch their masks in most settings, even indoors or in large groups. Masks are still required on buses, trains and other forms of public transportation, as well as airports.
To drive vaccinations, New York Mayor Bill de Blasio is offering vouchers for a Shake Shack burger or sandwich for residents who got their shots, while Six Flags Entertainment will give away 50,000 tickets to its Illinois theme parks to newly vaccinated residents in the state.
Ontario, Canada’s most populous province, is keeping a stay-home order in force into early June. CureVac and GlaxoSmithKline said early data from laboratory tests of their second-generation Covid-19 vaccine suggests good protection against some virus variants.